Cached score snapshot

US.BAX · Baxter International

110分制 53.6/110;5D動能v2 1/50;排序分 54.6/160 · Incomplete inputs

Ranking score 54.6/160
Main score 53.6/110
5D momentum v2 1/50
Rank #269
Setup grade F 23

Score breakdown

避免

Medium twelvedata

Score and price trend

F 23 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-11 07-16 08-18 09-21 10-16 $18.46$25.16$31.85 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.177 · anchors 120 +1.11% -0.96% / +3.25% 63% 2.6% Actual outcome pending · 1 / 3 bars observed
30D observation +7.79% +0.63% / +14.63% 77.4% 7.4% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +1.19% -0.63% / +3.05% 66.3% 2.5% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-06-11 → 2026-10-16 · 89 archived points · 2 Improving turn signal · 5 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 54.6
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 53.6/110 (避免)
5D momentum v2 1/50 (弱)
Score with momentum v2 54.6/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Incomplete score

此 snapshot 已計出評分,但以下輸入仍不完整;缺失維度以 0 分處理,請留意 audit 明细。

  • VIX_MISSING: VIX market context is required for market environment scoring

Market inputs

Bar count 60
ma20 26.364
ma50 24.716
close 25.83
prevClose 25.57
avgVolume20 5166480
volumeRatio 0.66
changePercent 1.02

Metrics snapshot

close 25.83
volume 3415000
changePercent 1.02

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 53.6/110
Main rating 避免
5D momentum v2 1/50
Score with momentum v2 54.6/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.1/5 · 較差

Dimension score 2.1/5
Dimension grade 較差

Sub-items

pbPoints 0.5
pePoints 0
epsPoints 0
roePoints 0
debtPoints 0.4
marginPoints 0
turnoverUsdM 88.2095
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.4

資金流 — 9.2/20 · 較差

Dimension score 9.2/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 1.6
obvPoints 4
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.BAX
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 7.8/15 · 較差

Dimension score 7.8/15
Dimension grade 較差

Sub-items

vix

score 0

details

source twelvedata+fred
missing true
vixClose n/a

trend

score 4

details

qqq

ma20 717.5105
ma50 711.085
name QQQ
close 718.96
points 2

spy

ma20 769.053
ma50 756.8572
name SPY
close 770.19
points 2
source twelvedata+fred
atrPct 2.7708
atrPoints 3
cciPoints 0.8
vixPoints 0
marketTrendPoints 4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 1
catalystCount 0
catalystPoints 2

風險管理 — 6.6/10 · 一般

Dimension score 6.6/10
Dimension grade 一般

Sub-items

position

score 1.4

details

atrPct 2.7708
turnoverUsdM 88.2095
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.BAX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 24.3986

strength_details

ma_score 1.5
atr_score 2
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.5
take_profit_price 27.1215
target_multiplier 1.6
technical_strength 1.38
take_profit_percent 5
positionPoints 1.4
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.5416
diversificationPoints 2

技術信號 — 17.9/30 · 較差

Dimension score 17.9/30
Dimension grade 較差

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 1.2
vcpPoints 3
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 3
vcp_reason 波幅收縮(31.4%→6.2%);量縮(v10/v30=0.65);跌縮量(近10日5日);站上MA50;Ready=Y;Confirm=N

vcp_metrics

up_days 4
vol_ref 6796600
down_days 5
vcp_ready true
above_ma50 true
avg_vol_10 4435890
avg_vol_20 5403865
avg_vol_30 6796600
range_pct_10 0.0616
range_pct_20 0.1103
range_pct_30 0.3136
up_expand_ok false
lookback_used 59
near_20d_high false
contraction_ok true
down_shrink_ok true
up_expand_days 0
breakout_20d_ok false
vol_ratio_10_30 0.6527
dist_to_20d_high 0.0782
down_shrink_days 5
breakout_level_20d 28.02
vcp_breakout_confirm false
contraction_ratio_10_30 0.1963
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.7
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.4
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 0.4

情緒分析 — 8/10 · 優秀

Dimension score 8/10
Dimension grade 優秀

Sub-items

sentiment

score 8

details

source finnhub_news_keyword_model
articleCount 1
negativeHits 0
positiveHits 1
sentimentScoreRaw 2.4

sentimentData

raw {"id":141769004,"url":"https://finnhub.io/api/news?id=8a8af4f0e29e2e47735ebf112f4099a3ab5bb4698e572bde01e1576f55be9137","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.","category":"company","datetime":1788809880,"headline":"BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure"}
raw_source {"id":141769004,"url":"https://finnhub.io/api/news?id=8a8af4f0e29e2e47735ebf112f4099a3ab5bb4698e572bde01e1576f55be9137","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.","category":"company","datetime":1788809880,"headline":"BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure"}, {"id":141761901,"url":"https://finnhub.io/api/news?id=ae0838e575efe910cc90ef8fcd8b9c5f3e1d67378b5b187ace84752d88733457","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The \"Drug Reconstitution Systems Market - Trends and Forecast Till 2035\" has been added to ResearchAndMarkets.com's offering. The global drug reconstitution systems market is projected to increase from approximately USD 5.9 billion in 2026 to USD 10.8 billion by 2035, representing a compound annual growth rate (CAGR) of about 7.0% during the forecast period. Market expansion is being supported by the growing pipeline of biologics, biosimilars, vaccines,","category":"company","datetime":1788778620,"headline":"Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA"}, {"id":141389181,"url":"https://finnhub.io/api/news?id=c4946b41c8282c227deb95c714d54b7c915c3aed19663ada0db5037a8f559c04","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.","category":"company","datetime":1788397223,"headline":"3 Value Stocks We Keep Off Our Radar"}, {"id":141365584,"url":"https://finnhub.io/api/news?id=9238febfa7a68ccaab2077197d44c6eac673d0ab770a383448cd0ebddc03e90c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 22.1% over the past six months while the S&P 500 was up 12.1%.","category":"company","datetime":1788272540,"headline":"3 Healthcare Stocks We Keep Off Our Radar"}, {"id":141352563,"url":"https://finnhub.io/api/news?id=62cc47117b3b9089b94543a3b43428caf46231c1d5d9006a1fe7d5275c3d64c8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Great stock picks are just the start to building a portfolio that can shelter you through whatever the market brings.","category":"company","datetime":1788100202,"headline":"Everything I Learned from My Hot Chart Summer, and How My 21 Stocks Picks Have Performed."}, {"id":141365585,"url":"https://finnhub.io/api/news?id=5c4fb5b21bf68a14c6fcb62a7f59ed0819c192d37aeb2a9136b2e00932e3b51d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"In recent days, IonQ appointed two new board members, veteran finance executive Dr. Eric Ball and former SkyWater chairman and Samsung North America CEO Timothy Baxter, adding deep capital markets and semiconductor leadership experience to its governance. The combination of Ball’s large-scale financing and M&A track record with Baxter’s chip industry and go-to-market expertise could be important as IonQ integrates SkyWater and scales its merchant quantum supply ambitions. Next, we’ll...","category":"company","datetime":1787771951,"headline":"Will New Capital Markets And Chip Leaders On The Board Change IonQ's (IONQ) Narrative"}, {"id":141314075,"url":"https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"BAX","summary":"Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.","category":"company","datetime":1787613074,"headline":"The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"}, {"id":141279223,"url":"https://finnhub.io/api/news?id=4655c88fe2a76e33cf900b32f5588227e71a01a98f847568ac876f0e3b9f8ec9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.","category":"company","datetime":1787322227,"headline":"3 Unpopular Stocks That Fall Short"}, {"id":141285640,"url":"https://finnhub.io/api/news?id=c989f94b9ac9f7018a4d15d217a7d7a22d26c615e8b39879f49ad312b613eebb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"John Rogers is expected to take the Deerfield, Illinois-based medical device company’s CFO seat on Oct. 1.","category":"company","datetime":1787245169,"headline":"Baxter hires new CFO with visa contingency"}, {"id":141271746,"url":"https://finnhub.io/api/news?id=3a66496e7658ed8f4e7c2928a1c6724916ad6c134fc13ede35fe57619aa8c86e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"John Rogers, who has experience leading change at companies, is expected to help Baxter’s turnaround gain traction. He joins Baxter after the company sold two business units.","category":"company","datetime":1787222487,"headline":"Baxter hires CFO from Smith & Nephew"}, {"id":141285642,"url":"https://finnhub.io/api/news?id=45888adeb0826065b8a67e1391d15234ea72cad8d0011556dbb4414a234e7288","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"DEERFIELD, Ill., August 19, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026.","category":"company","datetime":1787144400,"headline":"Baxter Appoints John Rogers Chief Financial Officer"}, {"id":141285649,"url":"https://finnhub.io/api/news?id=652b7fdc9fb655e8fb6500bb55bef325caf57afe91afc8f45c433cb99ac00882","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"DEERFIELD, Ill., August 18, 2026--Baxter International Inc. (NYSE:BAX) (\"Baxter\" or the \"Company\") today announced the pricing terms for its previously announced cash tender offers (each, an \"Offer\" and collectively, the \"Offers\") of the Company's validly tendered (and not validly withdrawn) notes set forth below (the \"Notes\") using a \"waterfall\" methodology under which the Company will accept the Notes in order of their respective acceptance priority levels noted in the table below (the \"Accept","category":"company","datetime":1787090160,"headline":"Baxter Announces Pricing for Its Upsized Cash Tender Offers"}, {"id":141285391,"url":"https://finnhub.io/api/news?id=e0b9d953643c35a423c8094f91673dbad14dd66af61053dc66b728126651cc14","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.","category":"company","datetime":1787074740,"headline":"COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?"}, {"id":141285643,"url":"https://finnhub.io/api/news?id=416b280dd9f30bad47204fb7c7a6024a4f83ff790d3b53d271adf60a31867286","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"DEERFIELD, Ill., August 18, 2026--Baxter International Inc. (NYSE:BAX) (\"Baxter\" or the \"Company\") today announced the early results of its previously announced cash tender offers (each, an \"Offer\" and collectively, the \"Offers\") for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the \"Notes\"). The Offers are being made pursuant to an Offer to Purchase, dated Aug. 4, 2026 (as it may be amended or supplemented from time to time, the \"Offer to Purchase\"), whic","category":"company","datetime":1787061600,"headline":"Baxter Announces Early Tender Results and Upsizing of Previously Announced Cash Tender Offers"}, {"id":141281565,"url":"https://finnhub.io/api/news?id=aa7893dba0b7ba30e6775070e552e7c107e3b8b80c13bda3b71dc4b7e59ba2ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Anita Zielinski will join Cardinal Health in November as its new chief accounting officer.","category":"company","datetime":1787055182,"headline":"Baxter’s interim CFO leaves for Cardinal Health"}, {"id":141285651,"url":"https://finnhub.io/api/news?id=09be328e9cd5cc95181b35ceed2da575a4b380f36fdfda9c21b58c12c7be61d3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.","category":"company","datetime":1786886940,"headline":"3 Stocks Under $50 with Questionable Fundamentals"}, {"id":141251978,"url":"https://finnhub.io/api/news?id=6a679e9dc3223f5f4d26900c4cb64486a33c4d0b9199983538ecbbe0d87ec892","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.","category":"company","datetime":1786738980,"headline":"WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?"}, {"id":141205682,"url":"https://finnhub.io/api/news?id=c145b4c41426e9b58210d33118893e1097cdb793d06d7fe21c7c073bb3e302c9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.","category":"company","datetime":1786625700,"headline":"Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins"}
data_source finnhub_news_keyword_model
article_count 1
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 2.4
source_article_count 18
discarded_article_count 17
sentimentPoints 8

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.1 5/110 42% 2.1
資金流 9.2 20/110 46% 9.2
市場環境 7.8 15/110 52% 7.8
催化劑 2 20/110 10% 2
風險管理 6.6 10/110 66% 6.6
技術信號 17.9 30/110 59.67% 17.9
情緒分析 8 10/110 80% 8

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 1/50
ret_5d -0.0115
max_score 50
max_total 50
raw_total 1
vcp_bonus 0
vol_ratio 0.632
ret_points 0
vol_points 0
range_ratio 1.198
volat_points 0
day_range_pct 0.0333
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.4

details

atrPct 2.7708
turnoverUsdM 88.2095
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.BAX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 24.3986

strength_details

ma_score 1.5
atr_score 2
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.5
take_profit_price 27.1215
target_multiplier 1.6
technical_strength 1.38
take_profit_percent 5
positionPoints 1.4
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.5416
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.1/5分
資金流分析總分: 9.2/20分
市場環境分析總分: 7.8/15分
催化劑分析: 2/20分
風險管理總分: 6.6/10分
技術信號分析總分: 17.9/30分
情緒分析: 8/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 0.7157
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.77
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value -97.08
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0969
kdj
d 29.81
j 36.59
k 32.07
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 弱流入
score 4
value 48.69
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 51190600
recentSlope -552710
previousSlope -1027550
rsi
value 48.9
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 27.953
position SAR喺價上
distancePct 8.22
previousTrend 下降
ma50
value 24.716
macd
macd 0.1923
trend 中性偏多
signal 0.4347
histogram -0.2423
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 26.4854
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 空升
ratio 0.66
score 2
avgVolume 5166480
currentVolume 3415000
derived
ma20 26.364
ma50 24.716
prevClose 25.57
avgVolume10 4341310
avgVolume20 5166480
changePercent 1.02
avgVolumeForScore 5166480
ma_cross
ma20 26.364
ma50 24.716
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 26.45
prevMa50 24.6304
spreadPct 6.67
isVolumeBreakout false
bollinger
lower 25.1373
upper 27.5907
position 中間
rsi_short
value 46.58
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.66

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.7708091366627956,
        "turnoverUsdM": 88.20945,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.BAX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 24.3986,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.5,
      "take_profit_price": 27.1215,
      "target_multiplier": 1.6,
      "technical_strength": 1.38,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.541618273325591,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 54.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 53.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 1
  },
  "market": {
    "ma20": 26.364,
    "ma50": 24.716,
    "close": 25.83,
    "prevClose": 25.57,
    "avgVolume20": 5166480,
    "volumeRatio": 0.66,
    "changePercent": 1.02
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 1,
    "details": {
      "ret_5d": -0.01148105625717566,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 1,
      "vcp_bonus": 0,
      "vol_ratio": 0.6319550914021723,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 1.1979639176069083,
      "volat_points": 0,
      "day_range_pct": 0.0332946186604723,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 54.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.1,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 42,
        "contribution": 2.1
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 7.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 52,
        "contribution": 7.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 66,
        "contribution": 6.6
      },
      {
        "raw": 17.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 59.67,
        "contribution": 17.9
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 53.6,
    "details": [
      "基本面分析總分: 2.1/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 7.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.6/10分",
      "技術信號分析總分: 17.9/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.1,
      "資金流": 9.2,
      "市場環境": 7.8,
      "情緒分析": 8,
      "技術信號": 17.9,
      "風險管理": 6.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 1,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 88.20945,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.BAX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 717.5105010500001,
                "ma50": 711.0850000400001,
                "name": "QQQ",
                "close": 718.96002,
                "points": 2
              },
              "spy": {
                "ma20": 769.0529934000002,
                "ma50": 756.85720062,
                "name": "SPY",
                "close": 770.19,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.7708091366627956,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 1,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 2.4
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141769004,
                "url": "https://finnhub.io/api/news?id=8a8af4f0e29e2e47735ebf112f4099a3ab5bb4698e572bde01e1576f55be9137",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.",
                "category": "company",
                "datetime": 1788809880,
                "headline": "BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure"
              }
            ],
            "raw_source": [
              {
                "id": 141769004,
                "url": "https://finnhub.io/api/news?id=8a8af4f0e29e2e47735ebf112f4099a3ab5bb4698e572bde01e1576f55be9137",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.",
                "category": "company",
                "datetime": 1788809880,
                "headline": "BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure"
              },
              {
                "id": 141761901,
                "url": "https://finnhub.io/api/news?id=ae0838e575efe910cc90ef8fcd8b9c5f3e1d67378b5b187ace84752d88733457",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The \"Drug Reconstitution Systems Market - Trends and Forecast Till 2035\" has been added to ResearchAndMarkets.com's offering. The global drug reconstitution systems market is projected to increase from approximately USD 5.9 billion in 2026 to USD 10.8 billion by 2035, representing a compound annual growth rate (CAGR) of about 7.0% during the forecast period. Market expansion is being supported by the growing pipeline of biologics, biosimilars, vaccines,",
                "category": "company",
                "datetime": 1788778620,
                "headline": "Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA"
              },
              {
                "id": 141389181,
                "url": "https://finnhub.io/api/news?id=c4946b41c8282c227deb95c714d54b7c915c3aed19663ada0db5037a8f559c04",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.",
                "category": "company",
                "datetime": 1788397223,
                "headline": "3 Value Stocks We Keep Off Our Radar"
              },
              {
                "id": 141365584,
                "url": "https://finnhub.io/api/news?id=9238febfa7a68ccaab2077197d44c6eac673d0ab770a383448cd0ebddc03e90c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 22.1% over the past six months while the S&P 500 was up 12.1%.",
                "category": "company",
                "datetime": 1788272540,
                "headline": "3 Healthcare Stocks We Keep Off Our Radar"
              },
              {
                "id": 141352563,
                "url": "https://finnhub.io/api/news?id=62cc47117b3b9089b94543a3b43428caf46231c1d5d9006a1fe7d5275c3d64c8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Great stock picks are just the start to building a portfolio that can shelter you through whatever the market brings.",
                "category": "company",
                "datetime": 1788100202,
                "headline": "Everything I Learned from My Hot Chart Summer, and How My 21 Stocks Picks Have Performed."
              },
              {
                "id": 141365585,
                "url": "https://finnhub.io/api/news?id=5c4fb5b21bf68a14c6fcb62a7f59ed0819c192d37aeb2a9136b2e00932e3b51d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "In recent days, IonQ appointed two new board members, veteran finance executive Dr. Eric Ball and former SkyWater chairman and Samsung North America CEO Timothy Baxter, adding deep capital markets and semiconductor leadership experience to its governance. The combination of Ball’s large-scale financing and M&A track record with Baxter’s chip industry and go-to-market expertise could be important as IonQ integrates SkyWater and scales its merchant quantum supply ambitions. Next, we’ll...",
                "category": "company",
                "datetime": 1787771951,
                "headline": "Will New Capital Markets And Chip Leaders On The Board Change IonQ's (IONQ) Narrative"
              },
              {
                "id": 141314075,
                "url": "https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BAX",
                "summary": "Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.",
                "category": "company",
                "datetime": 1787613074,
                "headline": "The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"
              },
              {
                "id": 141279223,
                "url": "https://finnhub.io/api/news?id=4655c88fe2a76e33cf900b32f5588227e71a01a98f847568ac876f0e3b9f8ec9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.",
                "category": "company",
                "datetime": 1787322227,
                "headline": "3 Unpopular Stocks That Fall Short"
              },
              {
                "id": 141285640,
                "url": "https://finnhub.io/api/news?id=c989f94b9ac9f7018a4d15d217a7d7a22d26c615e8b39879f49ad312b613eebb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "John Rogers is expected to take the Deerfield, Illinois-based medical device company’s CFO seat on Oct. 1.",
                "category": "company",
                "datetime": 1787245169,
                "headline": "Baxter hires new CFO with visa contingency"
              },
              {
                "id": 141271746,
                "url": "https://finnhub.io/api/news?id=3a66496e7658ed8f4e7c2928a1c6724916ad6c134fc13ede35fe57619aa8c86e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "John Rogers, who has experience leading change at companies, is expected to help Baxter’s turnaround gain traction. He joins Baxter after the company sold two business units.",
                "category": "company",
                "datetime": 1787222487,
                "headline": "Baxter hires CFO from Smith & Nephew"
              },
              {
                "id": 141285642,
                "url": "https://finnhub.io/api/news?id=45888adeb0826065b8a67e1391d15234ea72cad8d0011556dbb4414a234e7288",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "DEERFIELD, Ill., August 19, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026.",
                "category": "company",
                "datetime": 1787144400,
                "headline": "Baxter Appoints John Rogers Chief Financial Officer"
              },
              {
                "id": 141285649,
                "url": "https://finnhub.io/api/news?id=652b7fdc9fb655e8fb6500bb55bef325caf57afe91afc8f45c433cb99ac00882",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "DEERFIELD, Ill., August 18, 2026--Baxter International Inc. (NYSE:BAX) (\"Baxter\" or the \"Company\") today announced the pricing terms for its previously announced cash tender offers (each, an \"Offer\" and collectively, the \"Offers\") of the Company's validly tendered (and not validly withdrawn) notes set forth below (the \"Notes\") using a \"waterfall\" methodology under which the Company will accept the Notes in order of their respective acceptance priority levels noted in the table below (the \"Accept",
                "category": "company",
                "datetime": 1787090160,
                "headline": "Baxter Announces Pricing for Its Upsized Cash Tender Offers"
              },
              {
                "id": 141285391,
                "url": "https://finnhub.io/api/news?id=e0b9d953643c35a423c8094f91673dbad14dd66af61053dc66b728126651cc14",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.",
                "category": "company",
                "datetime": 1787074740,
                "headline": "COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?"
              },
              {
                "id": 141285643,
                "url": "https://finnhub.io/api/news?id=416b280dd9f30bad47204fb7c7a6024a4f83ff790d3b53d271adf60a31867286",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "DEERFIELD, Ill., August 18, 2026--Baxter International Inc. (NYSE:BAX) (\"Baxter\" or the \"Company\") today announced the early results of its previously announced cash tender offers (each, an \"Offer\" and collectively, the \"Offers\") for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the \"Notes\"). The Offers are being made pursuant to an Offer to Purchase, dated Aug. 4, 2026 (as it may be amended or supplemented from time to time, the \"Offer to Purchase\"), whic",
                "category": "company",
                "datetime": 1787061600,
                "headline": "Baxter Announces Early Tender Results and Upsizing of Previously Announced Cash Tender Offers"
              },
              {
                "id": 141281565,
                "url": "https://finnhub.io/api/news?id=aa7893dba0b7ba30e6775070e552e7c107e3b8b80c13bda3b71dc4b7e59ba2ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Anita Zielinski will join Cardinal Health in November as its new chief accounting officer.",
                "category": "company",
                "datetime": 1787055182,
                "headline": "Baxter’s interim CFO leaves for Cardinal Health"
              },
              {
                "id": 141285651,
                "url": "https://finnhub.io/api/news?id=09be328e9cd5cc95181b35ceed2da575a4b380f36fdfda9c21b58c12c7be61d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.",
                "category": "company",
                "datetime": 1786886940,
                "headline": "3 Stocks Under $50 with Questionable Fundamentals"
              },
              {
                "id": 141251978,
                "url": "https://finnhub.io/api/news?id=6a679e9dc3223f5f4d26900c4cb64486a33c4d0b9199983538ecbbe0d87ec892",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.",
                "category": "company",
                "datetime": 1786738980,
                "headline": "WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?"
              },
              {
                "id": 141205682,
                "url": "https://finnhub.io/api/news?id=c145b4c41426e9b58210d33118893e1097cdb793d06d7fe21c7c073bb3e302c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.",
                "category": "company",
                "datetime": 1786625700,
                "headline": "Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 1,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 2.4,
            "source_article_count": 18,
            "discarded_article_count": 17
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.9,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 3,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 3,
            "vcp_reason": "波幅收縮(31.4%→6.2%);量縮(v10/v30=0.65);跌縮量(近10日5日);站上MA50;Ready=Y;Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 6796600,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 4435890,
              "avg_vol_20": 5403865,
              "avg_vol_30": 6796600,
              "range_pct_10": 0.06155632984901278,
              "range_pct_20": 0.11033681765389075,
              "range_pct_30": 0.3135888501742161,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.6526630962540093,
              "dist_to_20d_high": 0.0781584582441114,
              "down_shrink_days": 5,
              "breakout_level_20d": 28.02,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.19629629629629625
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.7708091366627956,
              "turnoverUsdM": 88.20945,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.BAX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 24.3986,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.5,
            "take_profit_price": 27.1215,
            "target_multiplier": 1.6,
            "technical_strength": 1.38,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.541618273325591,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.BAX",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 0.7157,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.77
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -97.08
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0969
    },
    "kdj": {
      "d": 29.81,
      "j": 36.59,
      "k": 32.07,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 48.69
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 51190600,
      "recentSlope": -552710,
      "previousSlope": -1027550
    },
    "rsi": 48.9,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 27.953,
      "position": "SAR喺價上",
      "distancePct": 8.22,
      "previousTrend": "下降"
    },
    "ma50": 24.716,
    "macd": {
      "macd": 0.1923450571151868,
      "trend": "中性偏多",
      "signal": 0.4346815175161024,
      "histogram": -0.2423364604009156
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 26.4854,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.66,
      "score": 2,
      "avgVolume": 5166480,
      "currentVolume": 3415000
    },
    "derived": {
      "ma20": 26.364,
      "ma50": 24.716,
      "prevClose": 25.57,
      "avgVolume10": 4341310,
      "avgVolume20": 5166480,
      "changePercent": 1.02,
      "avgVolumeForScore": 5166480
    },
    "ma_cross": {
      "ma20": 26.364,
      "ma50": 24.716,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 26.45,
      "prevMa50": 24.6304,
      "spreadPct": 6.67,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 25.1373,
      "upper": 27.5907,
      "position": "中間"
    },
    "rsi_short": 46.58,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.66
    }
  }
}

Raw metrics JSON

{
  "close": 25.83,
  "volume": 3415000,
  "changePercent": 1.02
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.